Nadler, Michelle B.
Wilson, Brooke E.
Desnoyers, Alexandra
Valiente, Consolacion Molto
Saleh, Ramy R.
Amir, Eitan
Funding for this research was provided by:
Dream Hold 'Em for Life Clinical Oncology Fellow
National Breast Cancer Foundation
Article History
Received: 28 March 2023
Accepted: 22 December 2023
First Online: 3 January 2024
Competing interests
: Dr. Amir reports personal fees from Genetech/Roche, Apobiologix, Myriad Genetics, and Agendia, all outside the submitted work. No conflicts of interest for Drs. Michelle B. Nadler, Brooke E. Wilson, Alexandra Desnoyers, Consolacion Molto Valiente, and Ramy R. Saleh.